ACE2 and COVID-19: In order to identify suitable models, species studied in the context of COVID-19 were chosen based on similarity in the SARS-CoV-2 receptor angiotensin converting enzyme-2 (ACE-2) predicted in silico (Pach et al. 2020; Wu et al. 2020; Devaux et al. 2021).